Legal Information
Legal Proceedings: Nil
Legal Risks:
- Regulatory Compliance: Ensuring adherence to healthcare regulations to avoid fines and operational restrictions.
- Contractual Obligations: Managing risks related to breaches of contracts with suppliers and partners.
- Employment Law: Complying with labor laws to prevent disputes and claims.
- Intellectual Property: Protecting proprietary technologies and digital platforms from potential disputes.
- Medical Malpractice: Implementing quality assurance practices to minimize malpractice claims.
- Data Privacy: Ensuring the security of patient data to avoid breaches and legal actions.
We address these risks with rigorous compliance programs, comprehensive insurance, and proactive legal counsel.
Terms of the Offering
Subscription Process: Investors can subscribe to shares by completing the application form and providing the necessary documentation.
Rights and Obligations: Shareholders will enjoy rights to dividends from 2027-28 onwards, voting, and access to financial information, with obligations to adhere to company policies and regulations.
Risk Factors
Challenges: Potential challenges include regulatory changes, market competition, and technological disruptions.
Uncertainties: Economic fluctuations, changes in healthcare policy, and global health crises may impact business operations.
Project Cost
First Phase: Rs 162 Crores
Corporate Structure
Initial Registration: The project will be initially registered as a Private Limited Company to streamline operations.
Future Conversion: Plans are in place to convert the company to a Limited Company within 6 Months to expand growth and investment opportunities.
Authorized and Paid-Up Capital
- Capital: Rs 10,00,000
- Shares: 1,00,000 shares at Rs 10 each
Investment Details
Share Price: Each share offered at Rs 10,000 including a Rs 9,990 premium on a Rs 10 share.
Investment Tiers, Total Project Cost:
First Phase: Rs 162 Crores
Dividend Policy of The Company
Dividends will be distributed based on the company’s Net Profit After Tax (NPAF) for the financial year. (More details available in the Share Prospectus)
Exit Strategy: IPO Listing
We aim to list the company on the IPO by fiscal year 2034-35, offering an exit strategy for early investors and public investment opportunities.
Minimum Share Investment: Rs 2.5 Lakhs, 25 Shares.
